Fulminate anaerobic bacteremia after chemotherapy for metastatic breast cancer despite the prophylactic use of GCSF

Mila Petrova1 Clinic of Hematology and Oncology, Department of Medical Oncology, Medical Military Academy, Sofia, BulgariaCorrespondence[email protected]

Zhasmina Mihaylova1 Clinic of Hematology and Oncology, Department of Medical Oncology, Medical Military Academy, Sofia, Bulgaria

Albena Fakirova2 Department of Pathology, Medical Military Academy, Sofia, Bulgaria

References

CameronDManagement of chemotherapy-associated febrile neutropeniaBr J Cancer2009101S18S2219756002
PubMed Web of Science ®Google Scholar
KellySWheatleyDPrevention of febrile neutropenia: use of granulocyte colony-stimulating factorsBr J Cancer2009101S6S1019756005
PubMed Web of Science ®Google Scholar
LiutkauskieneSSveikataAJuozaityteESafety and efficacy study of the recombinant granulocyte colony-stimulating factor for prevention of neutropenia and neutropenia-related complications in women with metastatic breast cancer receiving docetaxel/doxorubicinMedicina (Kaunas)200945860060619773618
PubMed Web of Science ®Google Scholar
SoongDHajRLeungMGHigh rate of febrile neutropenia in patients with operable breast cancer receiving docetaxel and cyclophosphamideJ Clin Oncol20092726e101e10219652050
PubMed Web of Science ®Google Scholar
RenwickWPettengellRGreenMUse of filgrastim and pegfilgrastim to support delivery of chemotherapy: twenty years of clinical experienceBioDrugs200923317518619627169
PubMed Web of Science ®Google Scholar

Fulminate anaerobic bacteremia after chemotherapy for metastatic breast cancer despite the prophylactic use of GCSF

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Fulminate anaerobic bacteremia after chemotherapy for metastatic breast cancer despite the prophylactic use of GCSF

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date